Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLY-MYO-HF: CMR Risk Stratification in Cardiomyopathy
NCT02941315Phase 1Completed
- Sponsor
- Renji Hospital
- Start
- Dec 2016
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial (4 arms), sponsored by Renji Hospital. Primary endpoint: hospitalization due to heart failure at 6 months. Started Dec 2016; status: completed.
Beyond the preview
Go deeper on NCT02941315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02941315.